{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:20:30Z","timestamp":1794007230320,"version":"4.8.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008722","name":"Universitat de Girona","doi-asserted-by":"publisher","award":["MPCUdG2016\/036"],"award-info":[{"award-number":["MPCUdG2016\/036"]}],"id":[{"id":"10.13039\/100008722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["U1239"],"award-info":[{"award-number":["U1239"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007527","name":"Universit\u00e9 de Rouen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["SAF-2014-57160R"],"award-info":[{"award-number":["SAF-2014-57160R"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2014SGR-968"],"award-info":[{"award-number":["2014SGR-968"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12035-018-0972-5","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T17:00:28Z","timestamp":1520701228000},"page":"8263-8277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington\u2019s Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"N.","family":"Cabezas-Llobet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vidal-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xifr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"972_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"HDCRG","year":"1993","unstructured":"HDCRG (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington\u2019s disease collaborative research group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"972_CR2","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","volume":"119","author":"AD Lawrence","year":"1996","unstructured":"Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington\u2019s disease. Brain 119:1633\u20131645","journal-title":"Brain"},{"key":"972_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"972_CR4","first-page":"21","volume":"31","author":"A Montoya","year":"2006","unstructured":"Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington\u2019s disease. J Psychiatry Neurosci 31:21\u201329","journal-title":"J Psychiatry Neurosci"},{"key":"972_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K et al (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25:1\u201314","journal-title":"Neuropsychology"},{"key":"972_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","volume":"1","author":"A Giralt","year":"2012","unstructured":"Giralt A, Saavedra A, Alberch J, P\u00e9rez-Navarro E (2012) Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms. J Huntingtons Dis 1:155\u2013173","journal-title":"J Huntingtons Dis"},{"key":"972_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainresbull.2011.10.002","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Jones L, Dunnett SB (2012) Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington\u2019s disease. Brain Res Bull 88:81\u201393","journal-title":"Brain Res Bull"},{"key":"972_CR8","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1172\/JCI74809","volume":"124","author":"V Brito","year":"2014","unstructured":"Brito V, Giralt A, Enriquez-Barreto L, Puigdell\u00edvol M, Suelves N, Zamora-Moratalla A, Ballesteros JJ, Mart\u00edn ED et al (2014) Neurotrophin receptor p75NTR mediates Huntington\u2019s disease-associated synaptic and memory dysfunction. J Clin Invest 124:4411\u20134428","journal-title":"J Clin Invest"},{"key":"972_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"972_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","volume":"29","author":"J Nithianantharajah","year":"2008","unstructured":"Nithianantharajah J, Barkus C, Murphy M, Hannan AJ (2008) Gene\u2013environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington\u2019s disease transgenic mice. Neurobiol Dis 29:490\u2013504","journal-title":"Neurobiol Dis"},{"key":"972_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","volume":"8","author":"MT Usdin","year":"1999","unstructured":"Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington\u2019s disease mutation. Hum Mol Genet 8:839\u2013846","journal-title":"Hum Mol Genet"},{"key":"972_CR12","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","volume":"15","author":"AJ Milnerwood","year":"2006","unstructured":"Milnerwood AJ, Cummings DM, Dallerac GM, Brown JY, Vatsavayai SC, Hirst MC, Rezaie P, Murphy KP (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington\u2019s disease. Hum Mol Genet 15:1690\u20131703","journal-title":"Hum Mol Genet"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","volume":"23","author":"JH Cha","year":"2000","unstructured":"Cha JH (2000) Transcriptional dysregulation in Huntington\u2019s disease. Trends Neurosci 23:387\u2013392","journal-title":"Trends Neurosci"},{"key":"972_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","volume":"88","author":"KR Bowles","year":"2012","unstructured":"Bowles KR, Brooks SP, Dunnett SB, Jones L (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88:276\u2013284","journal-title":"Brain Res Bull"},{"key":"972_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","volume":"100","author":"S Sharma","year":"2015","unstructured":"Sharma S, Taliyan R (2015) Transcriptional dysregulation in Huntington\u2019s disease: the role of histone deacetylases. Pharmacol Res 100:157\u2013169","journal-title":"Pharmacol Res"},{"key":"972_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt A, Puigdell\u00edvol M, Carret\u00f3n O, Paoletti P, Valero J, Parra-damas A, Saura CA, Alberch J et al (2012) Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet 21:1203\u20131216","journal-title":"Hum Mol Genet"},{"key":"972_CR17","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, Gall CM, Simmons DA (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease. J Neurosci 27:4424\u20134434","journal-title":"J Neurosci"},{"key":"972_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Mart\u00edn ED, Gonzalez JR, Mil\u00e0 M, Ce\u00f1a V, Dierssen M, Canals JM et al (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 158:1234\u20131250","journal-title":"Neuroscience"},{"key":"972_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1749-6632.1994.tb19825.x","volume":"739","author":"A Arimura","year":"1994","unstructured":"Arimura A, Somogyvari-Vigh A, Weill C, Fiore RC, Tatsuno I, Bay V, Brenneman DE (1994) PACAP functions as a neurotrophic factor. Ann N Y Acad Sci 739:228\u2013243","journal-title":"Ann N Y Acad Sci"},{"key":"972_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/cne.10418","volume":"453","author":"J Hannibal","year":"2002","unstructured":"Hannibal J (2002) Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 453:389\u2013417","journal-title":"J Comp Neurol"},{"key":"972_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20\u00a0years after the discovery. Pharmacol Rev 61:283\u2013357","journal-title":"Pharmacol Rev"},{"key":"972_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/138161211795049679","volume":"17","author":"T Seaborn","year":"2011","unstructured":"Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effect of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17:204\u2013214","journal-title":"Curr Pharm Des"},{"key":"972_CR23","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2174\/138161211795589355","volume":"17","author":"D Reglodi","year":"2011","unstructured":"Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962\u2013972","journal-title":"Curr Pharm Des"},{"key":"972_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.10.004","volume":"155","author":"D Reglodi","year":"2017","unstructured":"Reglodi D, Renaud J, Tamas A, Tizabi Y, Soc\u00edas SB, Del-Bel E, Raisman-Vozari R (2017) Novel tactics for neuroprotection in Parkinson\u2019s disease: role of antibiotics, polyphenols and neuropeptides. Prog Neurobiol 155:120\u2013148","journal-title":"Prog Neurobiol"},{"key":"972_CR25","doi-asserted-by":"publisher","first-page":"13390","DOI":"10.1073\/pnas.97.24.13390","volume":"97","author":"D Vaudry","year":"2000","unstructured":"Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H (2000) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3\/CPP32. Proc Natl Acad Sci 97:13390\u201313395","journal-title":"Proc Natl Acad Sci"},{"key":"972_CR26","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.peptides.2007.04.013","volume":"28","author":"B Botia","year":"2007","unstructured":"Botia B, Basille M, Allais A, Raoult E, Falluel-Morel A, Galas L, Jolivel V, Wurtz O et al (2007) Neurotrophic effects of PACAP in the cerebellar cortex. Peptides 28:1746\u20131752","journal-title":"Peptides"},{"key":"972_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0306-4522(97)00545-9","volume":"84","author":"D Vaudry","year":"1998","unstructured":"Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, Vaudry H (1998) Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84:801\u2013812","journal-title":"Neuroscience"},{"key":"972_CR28","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2006.04148.x","volume":"99","author":"N Aubert","year":"2006","unstructured":"Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF et al (2006) PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. J Neurochem 99:1237\u20131250","journal-title":"J Neurochem"},{"key":"972_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1471-4159.2004.02810.x","volume":"91","author":"A Falluel-Morel","year":"2004","unstructured":"Falluel-Morel A, Aubert N, Vaudry D, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ (2004) Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J Neurochem 91:1231\u20131243","journal-title":"J Neurochem"},{"key":"972_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1046\/j.1471-4159.2003.02167.x","volume":"88","author":"SV Bhave","year":"2004","unstructured":"Bhave SV, Hoffman PL (2004) Phosphatidylinositol 3\u2032-OH kinase and protein kinase A pathways mediate the anti-apoptotic effect of pituitary adenylyl cyclase-activating polypeptide in cultured cerebellar granule neurons: modulation by ethanol. J Neurochem 88:359\u2013369","journal-title":"J Neurochem"},{"key":"972_CR31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1124\/mol.107.044792","volume":"73","author":"A Ravni","year":"2008","unstructured":"Ravni A, Vaudry D, Gerdin MJ, Eiden MV, Falluel-Morel A, Gonzalez BJ, Vaudry H, Eiden LE (2008) A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol Pharmacol 73:1688\u20131708","journal-title":"Mol Pharmacol"},{"key":"972_CR32","doi-asserted-by":"publisher","first-page":"e0120526","DOI":"10.1371\/journal.pone.0120526","volume":"10","author":"K Ogata","year":"2015","unstructured":"Ogata K, Shintani N, Hayata-Takano A, Kamo T, Higashi S, Seiriki K, Momosaki H, Vaudry D et al (2015) PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF. PLoS One 10:e0120526","journal-title":"PLoS One"},{"key":"972_CR33","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1096\/fj.10-180133","volume":"25","author":"D Rat","year":"2011","unstructured":"Rat D, Schmitt U, Tippmann F, Dewachter I, Theunis C, Wieczerzak E, Postina R, van Leuven F et al (2011) Neuropeptidepituitaryadenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer\u2019s disease-like pathology in amyloid precursor protein-transgenic mice. FASEB J 25:3208\u20133218","journal-title":"FASEB J"},{"key":"972_CR34","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1212\/WNL.0000000000000417","volume":"82","author":"P Han","year":"2014","unstructured":"Han P, Liang W, Baxter LC, Yin J, Tang Z, Beach TG, Caselli RJ, Reiman EM et al (2014) Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease. Neurology 82:1724\u20131728","journal-title":"Neurology"},{"key":"972_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.npep.2008.03.002","volume":"42","author":"G Wang","year":"2008","unstructured":"Wang G, Pan J, Tan Y, Sun X, Zhang Y, Zhou H et al (2008) Neuroprotective effects of PACAP27 in mice model of Parkinson\u2019s disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum. Neuropeptides 42:267\u2013276","journal-title":"Neuropeptides"},{"key":"972_CR36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1196\/annals.1317.083","volume":"1070","author":"A Tamas","year":"2006","unstructured":"Tamas A, Lubics A, Lengvari I, Reglodi D (2006) Protective effects of PACAP in excitotoxic striatal lesion. Ann N Y Acad Sci 1070:570\u2013574","journal-title":"Ann N Y Acad Sci"},{"key":"972_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"972_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V et al (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:1151\u20131122","journal-title":"Hum Mol Genet"},{"key":"972_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2015.09.001","volume":"95","author":"M Anglada-Huguet","year":"2016","unstructured":"Anglada-Huguet M, Vidal-Sancho L, Giralt A, Garc\u00eda-D\u00edaz Barriga G, Xifr\u00f3 X, Alberch J (2016) Prostaglandin E2 EP2 activation reduces memory decline in R6\/1 mouse model of Huntington\u2019s disease by the induction of BDNF-dependent synaptic plasticity. Neurobiol Dis 95:22\u201334","journal-title":"Neurobiol Dis"},{"key":"972_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuroscience.2009.02.028","volume":"160","author":"V Jolivel","year":"2009","unstructured":"Jolivel V, Basille M, Aubert N, de Jouffrey S, Ancian P, Le Bigot JF, Noack P, Massonneau M et al (2009) Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience 160:434\u2013451","journal-title":"Neuroscience"},{"key":"972_CR41","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.2174\/092986709789712899","volume":"16","author":"S Bourgault","year":"2009","unstructured":"Bourgault S, Vaudry D, Dejda A, Doan ND, Vaudry H, Fournier A (2009) Pituitary adenylate cyclase-activating polypeptide: focus on structure\u2013activity relationships of a neuroprotective peptide. Curr Med Chem 16:4462\u20134480","journal-title":"Curr Med Chem"},{"key":"972_CR42","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1471-4159.2008.05252.x","volume":"105","author":"X Xifr\u00f3","year":"2008","unstructured":"Xifr\u00f3 X, Garc\u00eda-Mart\u00ednez JM, Del Toro D, Alberch J, P\u00e9rez-Navarro E (2008) Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells. J Neurochem 105:1596\u20131612","journal-title":"J Neurochem"},{"key":"972_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","volume":"36","author":"X Xifr\u00f3","year":"2009","unstructured":"Xifr\u00f3 X, Giralt A, Saavedra A, Garc\u00eda-Mart\u00ednez JM, D\u00edaz-Hern\u00e1ndez M, Lucas JJ, Alberch J, P\u00e9rez-Navarro E (2009) Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington\u2019s disease: role in excitotoxicity. Neurobiol Dis 36:461\u2013469","journal-title":"Neurobiol Dis"},{"key":"972_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1471-4159.2012.07711.x","volume":"121","author":"M Anglada-Huguet","year":"2012","unstructured":"Anglada-Huguet M, Giralt A, Perez-Navarro E, Alberch J, Xifr\u00f3 X (2012) Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington\u2019s disease. J Neurochem 121:639\u2013648","journal-title":"J Neurochem"},{"key":"972_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1326-6-71","volume":"6","author":"A Giralt","year":"2011","unstructured":"Giralt A, Carret\u00f3n O, Lao-Peregrin C, Mart\u00edn ED, Alberch J (2011) Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6:71","journal-title":"Mol Neurodegener"},{"key":"972_CR46","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1007\/s12035-013-8556-x","volume":"49","author":"M Anglada-Huguet","year":"2014","unstructured":"Anglada-Huguet M, Xifr\u00f3 X, Giralt A, Zamora-Moratalla A, Mart\u00edn ED, Alberch J (2014) Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6\/1 mouse model of Huntington\u2019s disease. Mol Neurobiol 49:7847\u20137895","journal-title":"Mol Neurobiol"},{"key":"972_CR47","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1523\/JNEUROSCI.23-17-06856.2003","volume":"23","author":"JA Gorski","year":"2003","unstructured":"Gorski JA, Zeiler SR, Tamowski S, Jones KR (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23:6856\u20136865","journal-title":"J Neurosci"},{"key":"972_CR48","first-page":"495","volume-title":"Huntington\u2019s disease\u2014core concepts and current advances","author":"M Baydyuk","year":"2012","unstructured":"Baydyuk M, Xu B (2012) BDNF in Huntington\u2019s disease: role in pathogenesis and treatment. In: Tunali NE (ed) Huntington\u2019s disease\u2014core concepts and current advances, 1st edn. InTech, Rijeka (Croatia), pp. 495\u2013506","edition":"1"},{"key":"972_CR49","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"972_CR50","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"972_CR51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/JMN\/31:02:139","volume":"31","author":"J Fahrenkrug","year":"2007","unstructured":"Fahrenkrug J, Popovic N, Georg B, Brundin P, Hannibal J (2007) Decreased VIP and VPAC2 receptor expression in the biological clock of the R6\/2 Huntington\u2019s disease mouse. J Mol Neurosci 31:139\u2013148","journal-title":"J Mol Neurosci"},{"key":"972_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0169-328X(01)00153-X","volume":"92","author":"C Otto","year":"2001","unstructured":"Otto C, Martin M, Wolfer DP, Lipp HP, Maldonado R, Sch\u00fctz G (2001) Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res 92:78\u201384","journal-title":"Brain Res Mol Brain Res"},{"key":"972_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1101\/lm.34200","volume":"7","author":"M Roberto","year":"2000","unstructured":"Roberto M, Brunelli M (2000) PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CA1 region. Learn Mem 7:303\u2013311","journal-title":"Learn Mem"},{"key":"972_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jamaneurol.2014.3625","volume":"72","author":"P Han","year":"2015","unstructured":"Han P, Caselli RJ, Baxter L, Serrano G, Yin J, Beach TG, Reiman EM, Shi J (2015) Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease. JAMA Neurol 72:333\u2013339","journal-title":"JAMA Neurol"},{"key":"972_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.conb.2011.03.001","volume":"21","author":"W Xu","year":"2011","unstructured":"Xu W (2011) PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity. Curr Opin Neurobiol 21:306\u2013312","journal-title":"Curr Opin Neurobiol"},{"key":"972_CR56","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1471-4159.2000.740501.x","volume":"74","author":"H Hashimoto","year":"2000","unstructured":"Hashimoto H, Hagihara N, Koga K, Yamamoto K, Shintani N, Tomimoto S, Mori W, Koyama Y et al (2000) Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells. J Neurochem 74:501\u2013507","journal-title":"J Neurochem"},{"key":"972_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hipo.10010","volume":"12","author":"JF Guzowski","year":"2002","unstructured":"Guzowski JF (2002) Insights into immediate\u2013early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches. Hippocampus 12:86\u2013104","journal-title":"Hippocampus"},{"key":"972_CR58","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0896-6273(00)80737-0","volume":"22","author":"GE Hardingham","year":"1999","unstructured":"Hardingham GE, Chawla S, Cruzalegui FH, Bading H (1999) Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron 22:789\u2013798","journal-title":"Neuron"},{"key":"972_CR59","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1101\/lm.213906","volume":"13","author":"MA Wood","year":"2006","unstructured":"Wood MA, Attner MA, Oliveira AM, Brindle PK, Abel T (2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 13:609\u2013617","journal-title":"Learn Mem"},{"key":"972_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3072","volume":"12","author":"JY Altarejos","year":"2011","unstructured":"Altarejos JY, Montminy M (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12:141\u2013151","journal-title":"Nat Rev Mol Cell Biol"},{"key":"972_CR61","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","volume":"42","author":"E Korzus","year":"2004","unstructured":"Korzus E, Rosenfeld MG, Mayford M (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42:961\u2013972","journal-title":"Neuron"},{"key":"972_CR62","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","volume":"27","author":"CG Vecsey","year":"2007","unstructured":"Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, Cabrera SM, McDonough CB et al (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27:6128\u20136140","journal-title":"J Neurosci"},{"key":"972_CR63","doi-asserted-by":"publisher","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","volume":"26","author":"JM Oliveira","year":"2006","unstructured":"Oliveira JM, Chen S, Almeida S, Riley R, Gon\u00e7alves J, Oliveira CR, Hayden MR, Nicholls DG et al (2006) Mitochondrial-dependent Ca2+ handling in Huntington\u2019s disease striatal cells: effect of histone deacetylase inhibitors. J Neurosci 26:11174\u201311186","journal-title":"J Neurosci"},{"key":"972_CR64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hipo.22128","volume":"23","author":"A Giralt","year":"2013","unstructured":"Giralt A, Saavedra A, Carret\u00f3n O, Arum\u00ed H, Tyebji S, Alberch J, P\u00e9rez-Navarro E (2013) PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington\u2019s disease mouse model. Hippocampus 23:684\u2013695","journal-title":"Hippocampus"},{"key":"972_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/08977190410001723308","volume":"22","author":"DK Binder","year":"2004","unstructured":"Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 22:123\u2013131","journal-title":"Growth Factors"},{"key":"972_CR66","doi-asserted-by":"publisher","first-page":"20130132","DOI":"10.1098\/rstb.2013.0132","volume":"369","author":"H Lu","year":"2013","unstructured":"Lu H, Park H, Poo MM (2013) Spike-timing-dependent BDNF secretion and synaptic plasticity. Philos Trans R Soc Lond Ser B Biol Sci 369:20130132","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"972_CR67","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"972_CR68","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Mart\u00edn-Iba\u00f1ez R, Mu\u00f1oz MT, Mengod G, Ernfors P et al (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"972_CR69","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1073\/pnas.0811228106","volume":"106","author":"DA Simmons","year":"2009","unstructured":"Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice. Proc Natl Acad Sci U S A 106:4906\u20134911","journal-title":"Proc Natl Acad Sci U S A"},{"key":"972_CR70","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1074\/jbc.M209141200","volume":"278","author":"R Yaka","year":"2003","unstructured":"Yaka R, He DY, Phamluong K, Ron D (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-d-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J Biol Chem 278:9630\u20139638","journal-title":"J Biol Chem"},{"key":"972_CR71","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2004.01.030","volume":"360","author":"M Zink","year":"2004","unstructured":"Zink M, Otto C, Z\u00f6rner B, Zacher C, Sch\u00fctz G, Henn FA, Gass P (2004) Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor. Neurosci Lett 360:106\u2013108","journal-title":"Neurosci Lett"},{"key":"972_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101:57\u201366","journal-title":"Cell"},{"key":"972_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1326-6-81","volume":"6","author":"X Chen","year":"2011","unstructured":"Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C, Bezprozvanny I (2011) Dantrolene is neuroprotective in Huntington\u2019s disease transgenic mouse model. Mol Neurodegener 6:81","journal-title":"Mol Neurodegener"},{"key":"972_CR74","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"972_CR75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N et al (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"972_CR76","first-page":"1","volume":"58","author":"CL Wellington","year":"2000","unstructured":"Wellington CL, Leavitt BR, Hayden MR (2000) Huntington disease: new insights on the role of huntingtin cleavage. J Neural Transm Suppl 58:1\u201317","journal-title":"J Neural Transm Suppl"},{"key":"972_CR77","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","volume":"12","author":"S Waelter","year":"2001","unstructured":"Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 12:1393\u20131407","journal-title":"Mol Biol Cell"},{"key":"972_CR78","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/physrev.00027.2001","volume":"82","author":"MH Glickman","year":"2002","unstructured":"Glickman MH, Ciechanover A (2002) The ubiquitin\u2013proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373\u2013428","journal-title":"Physiol Rev"},{"key":"972_CR79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.npep.2008.03.002","volume":"42","author":"G Wang","year":"2008","unstructured":"Wang G, Pan J, Tan YY, Sun XK, Zhang YF, Zhou HY, Ren RJ, Wang XJ et al (2008) Neuroprotective effects of PACAP27 in mice model of Parkinson\u2019s disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum. Neuropeptides 42:267\u2013276","journal-title":"Neuropeptides"},{"key":"972_CR80","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cellsig.2008.10.008","volume":"21","author":"W Zhang","year":"2007","unstructured":"Zhang W, Smith A, Liu JP, Cheung NS, Zhou S, Liu K, Li QT, Duan W (2007) GSK3beta modulates PACAP-induced neuritogenesis in PC12 cells by acting downstream of Rap1 in a caveolae-dependent manner. Cell Signal 21:237\u2013245","journal-title":"Cell Signal"},{"key":"972_CR81","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","volume":"18","author":"MC Chiang","year":"2009","unstructured":"Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y (2009) The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin\u2013proteasome system. Hum Mol Genet 18:2929\u20132942","journal-title":"Hum Mol Genet"},{"key":"972_CR82","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.peptides.2007.05.002","volume":"28","author":"M Li","year":"2007","unstructured":"Li M, Maderdrut JL, Lertora JJ, Batuman V (2007) Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study. Peptides 28:1891\u20131895","journal-title":"Peptides"},{"key":"972_CR83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"J Born","year":"2002","unstructured":"Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5:514\u2013516","journal-title":"Nat Neurosci"},{"key":"972_CR84","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2362.2007.01832.x","volume":"37","author":"D Doberer","year":"2007","unstructured":"Doberer D, Gschwandtner M, Mosgoeller W, Bieglmayer C, Heinzl H, Petkov V (2007) Pulmonary and systemic effects of inhaled PACAP38 in healthy male subjects. Eur J Clin Investig 37:665\u2013672","journal-title":"Eur J Clin Investig"},{"key":"972_CR85","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuropharm.2015.05.014","volume":"108","author":"A Lamine","year":"2016","unstructured":"Lamine A, L\u00e9tourneau M, Doan ND, Maucotel J, Couvineau A, Vaudry H, Chatenet D, Vaudry D et al (2016) Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson\u2019s disease model. Neuropharmacology 108:440\u2013450","journal-title":"Neuropharmacology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0972-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T20:35:30Z","timestamp":1660595730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0972-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0972-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,10]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}